Page last updated: 2024-09-03

tafenoquine and Recrudescence

tafenoquine has been researched along with Recrudescence in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (4.55)	18.2507
2000's	2 (9.09)	29.6817
2010's	9 (40.91)	24.3611
2020's	10 (45.45)	2.80

Authors

Authors	Studies
Caridha, D; Kozar, MP; Lin, AJ; O'Neil, MT; Pybus, B; Sathunuru, R; Zhang, L	1
Breton, JJ; Chau, NH; Duparc, S; Ernest, TB; Goyal, N; Green, JA; Hien, TT; Hoa, NT; Jones, SW; Martin, A; Mohamed, K; Rolfe, K; Rousell, VM; Sharma, H; Tan, LK; Taylor, M; Vélez, ID	1
Herrera, S; Hsiang, MS; Llanos-Cuentas, A; Manrrique, P; Rosas-Aguirre, A	1
Nekkab, N; Watson, JA; White, M	1
Gautam, CS; Sharma, J; Singh, H; Singh, J	1
Cilley, B; Krause, PJ; Nagami, EH; Norris, AM; Rogers, R; Ting, MH; Vannier, E	1
Choi, JY; Kim, C; Kim, JD; Kim, JH; Lee, J; Suh, J; Yeom, JS	1
Markus, MB	1
Janković, SM; Kostić, M; Milosavljević, MN; Ranković, G; Stefanović, S	1
Devine, A; Dittrich, S; Howes, RE; Ley, B; Moore, KA; Price, DJ; Price, RN; Simpson, JA	1
Fernando, D; Rajapakse, S; Rodrigo, C	1
Ahmad, SS; Rahi, M; Sharma, A	1
White, NJ	1
Chu, CS; Freedman, DO	1
McCarthy, S; Quinn, JC	1
Taylor, AR; Watson, JA	1
Duparc, S; Green, JA; Koh, GCKW	1
Burrows, JN; Campo, B; Vandal, O; Wesche, DL	1
Fernando, SD; Rajapakse, S; Rodrigo, C	1
Edstein, MD; Kitchener, S; Nasveld, P	1
Crockett, M; Kain, KC	1
Braitman, DJ; Brewer, TG; Brueckner, RP; Chokejindachai, W; Heppner, DG; Horton, J; Kyle, DE; Looareesuwan, S; Milhous, WK; Schuster, BG; Tang, DB; Viriyavejakul, P; Walsh, DS; Wilairatana, P	1

Reviews

7 review(s) available for tafenoquine and Recrudescence

Article	Year
Tafenoquine for the treatment of Expert opinion on pharmacotherapy, 2022, Volume: 23, Issue:7 Topics: Aminoquinolines; Antimalarials; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Recurrence	2022
Tafenoquine for The Indian journal of medical research, 2021, Volume: 154, Issue:6 Topics: Aminoquinolines; Antimalarials; Female; Humans; Malaria, Vivax; Plasmodium vivax; Pregnancy; Primaquine; Recurrence	2021
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. The Cochrane database of systematic reviews, 2020, 09-06, Volume: 9 Topics: Adult; Aminoquinolines; Antimalarials; Chloroquine; Drug Administration Schedule; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Vivax; Parasitemia; Placebos; Primaquine; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention	2020
Tafenoquine and G6PD: a primer for clinicians. Journal of travel medicine, 2019, Jun-01, Volume: 26, Issue:4 Topics: Aminoquinolines; Antimalarials; Contraindications, Drug; Dose-Response Relationship, Drug; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Malaria; Randomized Controlled Trials as Topic; Recurrence	2019
Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax. Pathogens and global health, 2015, Volume: 109, Issue:3 Topics: Aminoquinolines; Antimalarials; Chemical and Drug Induced Liver Injury; Disease Eradication; Drug Discovery; Humans; Liver; Malaria, Vivax; Plasmodium vivax; Recurrence; Sporozoites	2015
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. The Cochrane database of systematic reviews, 2015, Apr-29, Issue:4 Topics: Adult; Aminoquinolines; Antimalarials; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Vivax; Primaquine; Primary Prevention; Randomized Controlled Trials as Topic; Recurrence	2015
Tafenoquine: a promising new antimalarial agent. Expert opinion on investigational drugs, 2007, Volume: 16, Issue:5 Topics: Aminoquinolines; Animals; Antimalarials; Humans; Malaria, Falciparum; Malaria, Vivax; Recurrence; Treatment Outcome	2007

Trials

2 trial(s) available for tafenoquine and Recrudescence

Article	Year
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial. The Lancet. Child & adolescent health, 2022, Volume: 6, Issue:2 Topics: Adolescent; Aminoquinolines; Antimalarials; Area Under Curve; Child; Child, Preschool; Chloroquine; Female; Humans; Malaria, Vivax; Male; Recurrence; Secondary Prevention; Tablets	2022
Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. The Journal of infectious diseases, 1999, Volume: 180, Issue:4 Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Vivax; Male; Prospective Studies; Recurrence; Thailand	1999

Article

Year

Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.

The Lancet. Child & adolescent health, 2022, Volume: 6, Issue:2

Topics: Adolescent; Aminoquinolines; Antimalarials; Area Under Curve; Child; Child, Preschool; Chloroquine; Female; Humans; Malaria, Vivax; Male; Recurrence; Secondary Prevention; Tablets

2022

Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.

The Journal of infectious diseases, 1999, Volume: 180, Issue:4

Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Vivax; Male; Prospective Studies; Recurrence; Thailand

1999

Other Studies

13 other study(ies) available for tafenoquine and Recrudescence

Article	Year
Antimalarial activities of new guanidylimidazole and guanidylimidazoline derivatives. Journal of medicinal chemistry, 2011, Oct-13, Volume: 54, Issue:19 Topics: Animals; Antimalarials; Crystallography, X-Ray; Guanidines; Humans; Imidazoles; Imidazolines; In Vitro Techniques; Macaca mulatta; Malaria; Mice; Microsomes, Liver; Plasmodium berghei; Plasmodium falciparum; Recurrence; Structure-Activity Relationship	2011
Tafenoquine for the prevention of Plasmodium vivax malaria relapse. The Lancet. Microbe, 2021, Volume: 2, Issue:5 Topics: Aminoquinolines; Humans; Malaria, Vivax; Primaquine; Recurrence	2021
Broad Antimicrobial Resistance in a Case of Relapsing Babesiosis Successfully Treated With Tafenoquine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-18, Volume: 76, Issue:4 Topics: Aminoquinolines; Atovaquone; Babesiosis; Drug Resistance; Humans; Recurrence; RNA, Ribosomal, 23S	2023
Cost-Benefit Analysis of Tafenoquine for Radical Cure of Journal of Korean medical science, 2022, Jul-11, Volume: 37, Issue:27 Topics: Aminoquinolines; Antimalarials; Cost-Benefit Analysis; Humans; Malaria, Vivax; Primaquine; Recurrence	2022
Killing of Plasmodium vivax by Primaquine and Tafenoquine. Trends in parasitology, 2019, Volume: 35, Issue:11 Topics: Aminoquinolines; Antimalarials; Humans; Hydrogen Peroxide; Malaria, Vivax; Plasmodium vivax; Primaquine; Recurrence	2019
Cost-utility of tafenoquine vs. primaquine for the radical cure (prevention of relapse) of Journal of chemotherapy (Florence, Italy), 2020, Volume: 32, Issue:1 Topics: Aminoquinolines; Antimalarials; Cost-Benefit Analysis; Humans; Malaria, Vivax; Markov Chains; Monte Carlo Method; Primaquine; Recurrence; Serbia	2020
Cost-Effectiveness Analysis of Sex-Stratified The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:1 Topics: Adult; Afghanistan; Aminoquinolines; Anemia, Hemolytic; Antimalarials; Chloroquine; Cost-Benefit Analysis; Ethiopia; Female; Glucosephosphate Dehydrogenase Deficiency; Hemizygote; Heterozygote; Homozygote; Humans; Indonesia; Malaria, Vivax; Male; Mass Screening; Medication Adherence; Plasmodium vivax; Primaquine; Quality-Adjusted Life Years; Recurrence; Sex Factors; Vietnam	2020
Relapses of BMJ global health, 2021, Volume: 6, Issue:2 Topics: Aminoquinolines; Disease Eradication; Humans; India; Malaria, Vivax; Recurrence	2021
Tafenoquine - A Radical Improvement? The New England journal of medicine, 2019, 01-17, Volume: 380, Issue:3 Topics: Aminoquinolines; Humans; Malaria, Vivax; Primaquine; Recurrence	2019
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria. The New England journal of medicine, 2019, 05-09, Volume: 380, Issue:19 Topics: Aminoquinolines; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Recurrence	2019
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria. The New England journal of medicine, 2019, 05-09, Volume: 380, Issue:19 Topics: Aminoquinolines; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Recurrence	2019
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria. Reply. The New England journal of medicine, 2019, 05-09, Volume: 380, Issue:19 Topics: Aminoquinolines; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Recurrence	2019
Tafenoquine for the treatment of recurrent Plasmodium vivax malaria. The American journal of tropical medicine and hygiene, 2007, Volume: 76, Issue:3 Topics: Adult; Aminoquinolines; Antimalarials; Chloroquine; Humans; Malaria, Vivax; Recurrence	2007